Literature DB >> 16644889

Haptoglobin polymorphism in a HIV-1 seropositive Brazilian population.

T R Zaccariotto1, E T Rosim, D Melo, P M D Garcia, R R Munhoz, F H Aoki, M de Fatima Sonati.   

Abstract

BACKGROUND: Haptoglobin (Hp) is a plasma protein with antioxidant and immunomodulatory properties. Three main genotypes/phenotypes (Hp1-1, Hp2-1, Hp2-2) show distinctive efficiencies in their activities and have been related to susceptibility and outcome in different diseases, including HIV infection.
OBJECTIVE: To compare Hp genotype distribution between HIV-1 seropositive patients and healthy controls.
METHODS: 387 Brazilian HIV-1 seropositive patients, subclassified as A, B, and C according to the Centers for Disease Control, were compared with 142 healthy controls. The influence of the polymorphism on iron status (serum iron, ferritin, transferrin, transferrin saturation), acute phase proteins (Hp, C reactive protein, fibrinogen, albumin), the HIV-1 viral load, and CD4+ T lymphocyte counts was examined.
RESULTS: Apart from finding lower Hp concentrations among individuals with genotype Hp2-2, no other significant difference was observed.
CONCLUSIONS: No association was found between Hp genotype and either HIV status or indices of HIV progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644889      PMCID: PMC1860288          DOI: 10.1136/jcp.2005.027375

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

Review 1.  Iron status and the outcome of HIV infection: an overview.

Authors:  V R Gordeuk; J R Delanghe; M R Langlois; J R Boelaert
Journal:  J Clin Virol       Date:  2001-02       Impact factor: 3.168

2.  Structure-function analysis of the antioxidant properties of haptoglobin.

Authors:  M Melamed-Frank; O Lache; B I Enav; T Szafranek; N S Levy; R M Ricklis; A P Levy
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

3.  Serum citrate levels, haptoglobin haplotypes and transferrin receptor (CD71) in patients with HIV-1 infection.

Authors:  A Pugliese; L Gennero; G P Pescarmona; M Beccattini; E Morra; G Orofino; D Torre
Journal:  Infection       Date:  2002-04       Impact factor: 3.553

4.  The effect of iron overload on in vitro HIV-1 infection.

Authors:  Hafsatou Ndama Traoré; Debra Meyer
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

5.  Acquisition of host cell-surface-derived molecules by HIV-1.

Authors:  I Frank; H Stoiber; S Godar; H Stockinger; F Steindl; H W Katinger; M P Dierich
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

6.  The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males.

Authors:  M R Langlois; M E Martin; J R Boelaert; C Beaumont; Y E Taes; M L De Buyzere; D R Bernard; H M Neels; J R Delanghe
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

7.  Haptoglobin polymorphism in human immunodeficiency virus infection: Hp0 phenotype limits depletion of CD4 cell counts in HIV-1-seropositive individuals.

Authors:  I K Quaye; J Brandful; F A Ekuban; B Gyan; N A Ankrah
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

8.  Haptoglobin polymorphism and iron homeostasis.

Authors:  Ernest Beutler; Terri Gelbart; Pauline Lee
Journal:  Clin Chem       Date:  2002-12       Impact factor: 8.327

9.  Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release.

Authors:  M Arredouani; P Matthijs; E Van Hoeyveld; A Kasran; H Baumann; J L Ceuppens; E Stevens
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

10.  Haptoglobin polymorphism, iron metabolism and mortality in HIV infection.

Authors:  J R Delanghe; M R Langlois; J R Boelaert; J Van Acker; F Van Wanzeele; G van der Groen; R Hemmer; C Verhofstede; M De Buyzere; D De Bacquer; V Arendt; J Plum
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

View more
  1 in total

1.  Haptoglobin gene subtypes in three Brazilian population groups of different ethnicities.

Authors:  Ana L Miranda-Vilela; Arthur K Akimoto; Penha C Z Alves; Cássia O Hiragi; Guilherme C Penalva; Silviene F Oliveira; Cesar K Grisolia; Maria N Klautau-Guimarães
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.